Becton, Dickinson and Company

Overview

Becton, Dickinson and Company, commonly known as BD, is a leading global medical technology company. The company is dedicated to advancing the world of health by developing innovative medical solutions that improve the lives of patients. BD operates in segments such as medical devices, biosciences, and diagnostics.

Therapeutic areas

API / Drug Master Files

Becton, Dickinson and Company holds 0 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• BD CELL MAB MEDIUM ANIMAL COMPONENT FREEInactive2002-09-30
• BD CELL MAB MEDIUM SERUM-FREEInactive2002-09-30
• BD CELL MAB MEDIUM BASE W/O PHENOL REDInactive2002-01-11
• BD CELL MAB MEDIUM, QUANTUM YIELDInactive2002-01-11
• PROTEOSE PEPTONE N0.3Inactive2000-08-25
• ADENOSINE CYCLIC PHOSPHATE MANUF. BY SCHWARZ BIORESEARCHInactive1968-12-19
• TRITIATED CYTIDINEInactive1968-12-03
• DIBUTYRYL CYCLIC MONOPHOSPHATE SODIUM MANUF. BY SCHWARZ BIORESEARCHInactive1968-05-13

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Becton, Dickinson and Company in our records. PharmaTek screens the full directory against live FDA enforcement data.